ArticleJACC. Case reports2026
CIED-Related Tricuspid Regurgitation Managed With Lead Extraction, Leadless Pacing, and Annuloplasty.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundManagement of cardiac implantable electronic device-related tricuspid regurgitation remains challenging, particularly when lead interference coexists with annular dilation. CASE SUMMARY: A 69-year-old woman with a single-chamber pacemaker presented with symptomatic severe lead-related tricuspid regurgitation. Echocardiography demonstrated septal leaflet impingement by the pacing lead and marked annular dilation. Because isolated lead extraction was unlikely to restore valve competence, transvenous lead extraction, leadless pacemaker implantation, and transcatheter tricuspid annuloplasty were performed. At 3-month follow-up, tricuspid regurgitation had decreased to a mild-to-moderate level, with improvement in heart failure symptoms. DISCUSSION: This case illustrates a feasible multimodality strategy for selected patients with cardiac implantable electronic device-related tricuspid regurgitation. Combining lead extraction, leadless pacing, and transcatheter annuloplasty may relieve mechanical leaflet interference, avoid renewed transvalvular lead disruption, and reduce annular dilation. TAKE-HOME MESSAGES: Compared with conventional transvalvular leads, leadless pacing causes less interference with tricuspid valve motion and may therefore reduce lead-related regurgitation. A combined approach involving lead extraction, leadless pacing, and transcatheter tricuspid annuloplasty can provide a practical therapeutic pathway for cardiac implantable electronic device-related tricuspid regurgitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.